Canopy Growth Corporation (CGC) Financials
CGC Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Dec. 31, 2025 | 1.1 billion | 348.3 million |
| Sept. 30, 2025 | 768.3 million | 239.7 million |
| June 30, 2025 | 664.9 million | 305.5 million |
| March 31, 2025 | 639.1 million | 299.8 million |
CGC Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Dec. 31, 2025 | -19.1 million | 888741 |
| Sept. 30, 2025 | -14.0 million | 1.4 million |
| June 30, 2025 | -8.7 million | -72760 |
| March 31, 2025 | -25.3 million | -13.0 million |
CGC Net Income
No data available :(
CGC Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Dec. 31, 2025 | 371.6 million | 225.2 million | 30.2 million |
| Sept. 30, 2025 | 214.1 million | 162.5 million | 22.4 million |
| June 30, 2025 | 105.6 million | 212.4 million | 23.9 million |
| March 31, 2025 | 91.6 million | 208.8 million | 30.9 million |
CGC Shares Outstanding
CGC Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Dec. 31, 2025 | 1.9 million | - | 29.8 million | 16.0 million |
| Sept. 30, 2025 | 1.1 million | - | 22.7 million | 10.9 million |
| June 30, 2025 | 1.1 million | - | 22.4 million | 11.6 million |
| March 31, 2025 | 2.2 million | 1.9 million | 6.1 million | 10.6 million |
CGC Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Dec. 31, 2025 | 74.6 million | 53.1 million |
| Sept. 30, 2025 | 47.9 million | 32.2 million |
| June 30, 2025 | 53.0 million | 39.8 million |
| March 31, 2025 | 45.3 million | 37.9 million |
CGC Revenue by Segment
Graph available only for paid members. Upgrade to see it.
CGC
Price: $1.03
52 week price:
Earnings Per Share: -1.35 USD
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: Canada
Volume: 11.1 million
Market Capitalization: 476.0 million